Literature DB >> 18568567

Image-guided transvaginal drainage of pelvic abscesses and fluid collection using a modified Seldinger technique.

Seung Ho Kim1, Seung Hyup Kim, Heon Han, Sam Soo Kim, Ji Yeon Lee, Yong Hwan Jeon.   

Abstract

BACKGROUND: Transvaginal drainage using the trocar method is advantageous as a single-step procedure; however, the procedure may occasionally be difficult to perform, due to buckling of the catheter in the elastic vaginal tissues, despite the presence of a stiff stylet.
PURPOSE: To evaluate the efficacy and the safety of image-guided transvaginal drainage of pelvic abscesses and fluid collection using a modified Seldinger technique.
MATERIAL AND METHODS: Fifteen patients (mean age 43 years, range 24-82 years) who underwent transvaginal aspiration (n=1) or catheter drainage (n=14) guided by ultrasound and fluoroscopy were enrolled in this retrospective study. A small coronal incision was performed to facilitate puncture using an 18G needle, tract dilatation, and the insertion of a drainage catheter by the Seldinger technique. Outcome was analyzed with respect to clinical success, technical success, and procedure-related complications.
RESULTS: The overall clinical success rate was 87% (13/15 cases). The success rate of catheter drainage was 86% (12/14 cases), and the use of aspiration alone was successful in one patient. Technical success was achieved in all patients, without procedure-related complications.
CONCLUSION: Image-guided transvaginal drainage with a modified Seldinger technique can be a safe and effective alternative treatment for pelvic abscesses and fluid collection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568567     DOI: 10.1080/02841850802065026

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  1 in total

1.  Pelvic abscess drainage: outcome with factors affecting the clinical success.

Authors:  Devrim Akıncı; Onur Ergun; Çağdaş Topel; Türkmen Çiftçi; Okan Akhan
Journal:  Diagn Interv Radiol       Date:  2018 May-Jun       Impact factor: 2.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.